1Executive Summary 1.1 Tuberculosis Diagnostics – Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Tuberculosis Diagnostics Market Definition And Segmentations
6.4 Market Segmentation By Test Type
6.4.1 Radiographic Test
6.4.2 Nucleic Acid Testing
6.4.3 Cytokine Detection Test
6.4.4 Drug Resistance Test
6.4.5 Skin Test/Mantoux Test (TST)
6.4.6 Blood Test/Serology Test
6.4.7 Smear Microscopy
6.4.8 Cultured-Based Tests
6.4.9 Other Test Types
6.5 Market Segmentation By Disease Stage
6.5.1 Latent Tuberculosis
6.5.2 Active Tuberculosis
6.6 Market Segmentation By End-User
6.6.1 Hospitals And Diagnostic Laboratories
6.6.2 Physician’s Office Laboratories
6.6.3 Reference Laboratories
6.6.4 Academics And Research Facilities
7 Major Market Trends
7.1 Next Generation Sequencing (NGS) Platforms For TB Diagnostics
7.2 New Product Innovations For Advanced Diagnostics Solutions
7.3 Introduction Of T Cell Tests To Transform TB Detection With Precision And Reliability
7.4 Artificial Intelligence (AI)-Based Tuberculosis Diagnostics To Enhance Accuracy
7.5 Use Of Portable Devices To Enhance Access In Resource-Limited Settings
7.6 Strategic Collaborations Among Market Players To Enhance Access To Diagnostics
7.7 Technology Advancements To Transform The Landscape Of TB Detection
7.8 Introduction Of Blood-Based Tests For Minimally Invasive Detection Of TB
8 Tuberculosis Diagnostics Market – Macro-Economic Scenario
8.1 COVID-19 Impact On The Tuberculosis Diagnostics Market
8.2 Impact Of The War In Ukraine On The Tuberculosis Diagnostics Market
8.3 Impact Of High Inflation On The Tuberculosis Diagnostics Market
9 Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)
9.2.1 Market Drivers 2018 – 2023
9.2.2 Market Restraints 2018 – 2023
9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)
9.3.1 Market Drivers 2023 – 2028
9.3.2 Market Restraints 2023 – 2028
10 Global Tuberculosis Diagnostics Market Segmentation
10.1 Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
11 Tuberculosis Diagnostics Market, Regional and Country Analysis
11.1 Global Tuberculosis Diagnostics Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Tuberculosis Diagnostics Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.1.1 Market Overview
12.1.2 Region Information
12.1.3 Market Information
12.1.4 Background Information
12.1.5 Government Initiatives
12.1.6 Regulations
12.1.7 Regulatory Bodies
12.1.8 Major Associations
12.1.9 Taxes Levied
12.1.10 Corporate Tax Structure
12.1.11 Investments
12.1.12 Major Companies
12.2 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Tuberculosis Diagnostics Market: Country Analysis
12.6 China Market
12.7 Summary
12.7.1 Market Overview
12.7.2 Country Information
12.7.3 Market Information
12.7.4 Background Information
12.7.5 Government Initiatives
12.7.6 Regulations
12.7.7 Regulatory Bodies
12.7.8 Major Associations
12.7.9 Taxes Levied
12.7.10 Corporate Tax Structure
12.7.11 Investments
12.7.12 Major Companies
12.8 China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.9 China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.10 China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.13 India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.14 India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.20 Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.22 Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.1.1 Market Overview
13.1.2 Region Information
13.1.3 Market Information
13.1.4 Background Information
13.1.5 Government Initiatives
13.1.6 Regulations
13.1.7 Regulatory Bodies
13.1.8 Major Associations
13.1.9 Taxes Levied
13.1.10 Corporate Tax Structure
13.1.11 Investments
13.1.12 Major Companies
13.2 Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Tuberculosis Diagnostics Market: Country Analysis
13.6 UK Market
13.7 UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.8 UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.10 Germany Market
13.11 Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.14 France Market
13.15 France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.16 France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.17 France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.18 Italy Market
13.19 Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.20 Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.22 Spain Market
13.23 Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.24 Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.1.1 Market Overview
14.1.2 Region Information
14.1.3 Market Information
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes Levied
14.1.10 Corporate Tax Structure
14.1.11 Investments
14.1.12 Major Companies
14.2 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Tuberculosis Diagnostics Market: Country Analysis
14.6 Russia Market
14.7 Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.8 Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15 North America Market
15.1 Summary
15.1.1 Market Overview
15.1.2 Region Information
15.1.3 Market Information
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes Levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.3 North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Tuberculosis Diagnostics Market: Country Analysis
15.6 USA Market
15.7 Summary
15.7.1 Market Overview
15.7.2 Country Information
15.7.3 Market Information
15.7.4 Background Information
15.7.5 Government Initiatives
15.7.6 Regulations
15.7.7 Regulatory Bodies
15.7.8 Major Associations
15.7.9 Taxes Levied
15.7.10 Corporate Tax Structure
15.7.11 Investments
15.7.12 Major Companies
15.8 USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.9 USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.10 USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.11 Canada Market
15.12 Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.14 Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16 South America Market
16.1 Summary
16.1.1 Market Overview
16.1.2 Region Information
16.1.3 Market Information
16.1.4 Background Information
16.1.5 Government Initiatives
16.1.6 Regulations
16.1.7 Regulatory Bodies
16.1.8 Major Associations
16.1.9 Taxes Levied
16.1.10 Corporate Tax Structure
16.1.11 Investments
16.1.12 Major Companies
16.2 South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.3 South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Tuberculosis Diagnostics Market: Country Analysis
16.6 Brazil Market
16.7 Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.1.1 Market Overview
17.1.2 Region Information
17.1.3 Market Information
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes Levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market
18.1 Summary
18.1.1 Market Overview
18.1.2 Region Information
18.1.3 Market Information
18.1.4 Background Information
18.1.5 Government Initiatives
18.1.6 Regulations
18.1.7 Regulatory Bodies
18.1.8 Major Associations
18.1.9 Taxes Levied
18.1.10 Corporate Tax Structure
18.1.11 Investments
18.1.12 Major Companies
18.2 Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18.3 Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape And Company Profiles
19.1 Company Profiles
19.2 Becton, Dickinson and Company
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Business Strategy
19.2.4 Financial Overview
19.3 Qiagen N.V.
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Business Strategy
19.3.4 Financial Overview
19.4 F. Hoffman-La Roche Ltd
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 BioMerieux SA
19.5.1 Company Overview
19.5.2 Products And Services
19.5.3 Business Strategy
19.5.4 Financial Overview
19.6 Danaher Corporation (Cepheid, Inc.)
19.6.1 Company Overview
19.6.2 Products And Services
19.6.3 Business Strategy
19.6.4 Financial Overview
20 Tuberculosis Diagnostics Market Other Major And Innovative Companies
20.1 Abbott Laboratories, Inc
20.1.1 Company Overview
20.1.2 Products And Services
20.2 Bio-Rad Laboratories, Inc
20.2.1 Company Overview
20.2.2 Products And Services
20.3 Thermo Fisher Scientific, Inc
20.3.1 Company Overview
20.3.2 Products And Services
20.4 PerkinElmer, Inc
20.4.1 Company Overview
20.4.2 Products And Services
20.5 Bio-Techne Corporation
20.5.1 Company Overview
20.5.2 Products And Services
20.6 Hologic, Inc
20.6.1 Company Overview
20.6.2 Products And Services
20.7 Laboratory Corporation
20.7.1 Company Overview
20.7.2 Products And Services
20.8 Siemens Healthineers
20.8.1 Company Overview
20.8.2 Products And Services
20.9 Akonni Biosystems Inc
20.9.1 Company Overview
20.9.2 Products And Services
20.10 Hain Lifescience GmbH
20.10.1 Company Overview
20.10.2 Products And Services
20.11 Creative Diagnostics
20.11.1 Company Overview
20.11.2 Products And Services
20.12 Lionex GmbH
20.12.1 Company Overview
20.12.2 Products And Services
20.13 Genedrive PLC
20.13.1 Company Overview
20.13.2 Products And Services
20.14 Mylab Discovery Solutions Pvt. Ltd
20.14.1 Company Overview
20.14.2 Products And Services
20.15 AdvaCare Pharma
20.15.1 Company Overview
20.15.2 Products And Services
21 Competitive Benchmarking
22 Competitive Dashboard
23 Key Mergers And Acquisitions
23.1 Molbio Diagnostics Acquired Prognosys Medical Systems
23.2 SD Biosensor Acquired Relab
23.3 Hologic Inc. Acquired Mobidiag Oy
23.4 PerkinElmer Acquired Oxford Immunotec
23.5 Thermo Fisher Scientific Acquired Mesa Biotech Inc.
24 Opportunities And Strategies
24.1 Global Tuberculosis Diagnostics Market In 2028 – Countries Offering Most New Opportunities
24.2 Global Tuberculosis Diagnostics Market In 2028 – Segments Offering Most New Opportunities
24.3 Global Tuberculosis Diagnostics Market In 2028 – Growth Strategies
24.3.1 Market Trend Based Strategies
24.3.2 Competitor Strategies
25 Tuberculosis Diagnostics Market, Conclusions And Recommendations
25.1 Conclusions
25.2 Recommendations
25.2.1 Product
25.2.2 Place
25.2.3 Price
25.2.4 Promotion
25.2.5 People
26 Appendix
26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer